All Members

On day three of the STS 2025 Annual Meeting, Dr. Jeremiah Hayanga, professor of thoracic surgery, Department of Cardiovascular and Thoracic Surgery, West Virginia University, will present a session titled, Endobronchial Valve Therapy (EVT) versus Lung Volume Reduction Survey (LVRS) in the US. In this presentation, Dr. Hayanga and his research team will share new, risk-adjusted study results that provide fresh insights into treatments for severe emphysema.

Recent findings suggest that as surgical practices evolve, LVRS may offer better long-term results for patients with advanced emphysema compared to EBV therapy. Although EBV patients had shorter hospital stays, lower charges, and fewer pre-existing conditions, the study revealed they experienced more complications and a higher risk of death over time than those who underwent LVRS.

To be held Sunday, Jan. 25, at 8 a.m. during the larger “Modernized Solutions for Lung Failure, From Bench to Bedside” session, Dr. Hayanga will also discuss the limitations of lung transplantation as a solution for severe emphysema due to the shortage of donor organs. 

“Surgical lung volume reduction, explored in the late 1990s, did not gain widespread acceptance due to its associated risks and the small pool of patients who were thought to benefit,” says Dr. Hayanga. “However, with advancements in surgical techniques and risk management, LVRS has seen improved outcomes, offering hope for patients who are not candidates for lung transplants.”

During the Saturday, Jan. 25 presentation of the James S. Tweddell Memorial Paper for Congenital Heart Surgery, Reilly Hobbs, MD, from the University of Utah Medical Center will explore the relationship between the volume of Norwood procedures performed at a center and patient outcomes based on findings from the National Pediatric Cardiology – Quality Improvement Collaborative Database study.

Image

The Norwood procedure, a critical surgery for infants with single ventricle defects, has been extensively studied, but findings on how case volume affects outcomes have been inconsistent. This study examines data that clarifies the relationship between center case volume and survival and morbidity in patients undergoing this complex surgery.

In presenting the findings of the study, Congenital Heart Surgery, Volume-Outcome Relationship of Norwood Procedures: Insights from the National Pediatric Cardiology – Quality Improvement Collaborative Database, Dr. Hobbs will explain how centers were grouped based on their annual case volume—low, medium, and high—and how preoperative risk factors, complications, and survival outcomes were compared. He will also highlight how patients at high-volume centers had better outcomes than those at low-volume centers, including higher survival rates and lower mortality, particularly among patients with additional high-risk features. 

“The findings indicate that the number of Norwood procedures performed at a center significantly impacts patient outcomes with high-volume centers consistently achieving better results than low-volume centers,” says Dr. Hobbs. “It’s essential to emphasize the role of case volume in complex congenital heart surgeries and explore the potential benefits of directing high-risk patients to more experienced centers. Further research is needed to identify the key factors that contribute to improved outcomes at high-volume centers, ultimately enhancing care for single ventricle patients.”
 

In a landmark achievement for healthcare in Southeast Asia, St. Luke's Medical Center has launched the region's first robotic cardiac surgery program. This historic initiative was made possible through a collaborative effort between St. Luke's multidisciplinary team, led by Drs. Marvin Martinez and Ramiro Pablo, and the expert team from West Virginia University's (WVU) Heart and Vascular Institute, including Dr. Vinay Badhwar, Dr. Lawrence Wei, and physician assistant Herald Fe.

The program debuted with a series of innovative robotic-assisted cardiac procedures, showcasing the transformative potential of this advanced technology. Among the groundbreaking surgeries performed were:

• Robotic MIDCAB (Minimally Invasive Direct Coronary Artery Bypass)
• Robotic bileaflet mitral valve repair for severe mitral regurgitation (MR) due to bileaflet myxomatous disease
• Robotic mitral valve repair for endocarditis, including anterior mitral leaflet perforation
• Robotic adult congenital atrial septal reconstruction using a bovine patch for a patient with a common atrium
• Robotic aortic valve replacement (AVR) for a patient from Papua New Guinea

The first robotic valve surgery—a repair of a severely regurgitant mitral valve in a 40-year-old patient—marked a defining moment in the program's success. With guidance from WVU's Heart and Vascular Institute, the procedure was completed with precision and excellence, underscoring the collaboration's impact.

Dr. Pablo expressed his excitement, saying, "This is a monumental step forward for cardiac care in Southeast Asia. Our partnership with the WVU team has empowered us to provide patients with less invasive, highly precise procedures and faster recoveries."

Dr. Martinez added, "Establishing this robotic cardiac surgery program has been a dream realized through our team's dedication and the invaluable expertise of our WVU partners. This is just the beginning of a new era in cardiac care."

Reflecting on the collaboration, Dr. Badhwar remarked, "Teamwork truly makes the dream work. The exceptional multidisciplinary team at St. Luke's has shown that vision, determination, and collaboration can achieve extraordinary outcomes."

St. Luke's Robotic Cardiac Surgery Program is set to advance care across the region, offering minimally invasive options that reduce pain, recovery time, and the risk of complications.